Медицинская библиотека · Osteoarthritis and cartilage · 2013

Intra-articular injection of the selective cyclooxygenase-2 inhibitor meloxicam (Mobic) reduces experimental osteoarthritis and nociception in rats.

Wen Z-H, Tang C-C, Chang Y-C, Huang S-Y, Chen C-H, Wu S-C, Hsieh S-P, Hsieh C-S, Wang K-Y, Lin S-Y, Lee H-L, Lee C-H, Kuo H-C, Chen W-F, Jean Y-H

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

To study the effect of intra-articular injection of meloxicam (Mobic) on the development of osteoarthritis (OA) in rats and examine concomitant changes in nociceptive behavior and the expression of mitogen-activated protein kinases (MAPKs) in articular cartilage chondrocytes.

METHODS

OA was induced in Wistar rats by right anterior cruciate ligament transection (ACLT); the left knee was not treated. The OA + meloxicam (1.0 mg) group was injected intra-articularly in the ACLT knee with 1.0 mg of meloxicam once a week for 5 consecutive weeks starting 5 weeks after ACLT. The OA + meloxicam (0.25 mg) group was treated similarly with 0.25 mg meloxicam. The sham group underwent arthrotomy only and received vehicle of 0.1 mL sterile 0.9% saline injections, whereas the naive rats in meloxicam-only groups were treated similarly with 1.0- and 0.25-mg meloxicam. Nociception was measured as secondary mechanical allodynia and hind paw weight-bearing distribution at before (pre-) and 5, 10, 15, and 20 weeks post-ACLT. Histopathology of the cartilage and synovia was examined 20 weeks after ACLT. Immunohistochemical analysis was performed to examine the effect of meloxicam on MAPKs (p38, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinase (ERK)) expression in the articular cartilage chondrocytes.

RESULTS

OA rats receiving intra-articular meloxicam treatment showed significantly less cartilage degeneration and synovitis than saline-treated controls. Nociception were improved in the OA + meloxicam groups compared with the OA group. Moreover, meloxicam attenuated p38 and JNK but enhanced ERK expression in OA-affected cartilage.

CONCLUSIONS

Intra-articular injection of meloxicam (1) attenuates the development of OA, (2) concomitantly reduces nociception, and (3) modulates chondrocyte metabolism, possibly through inhibition of cellular p38 and JNK, but enhances ERK expression.

Для цитирования: Wen Z-H, Tang C-C, Chang Y-C, Huang S-Y, Chen C-H, Wu S-C, Hsieh S-P, Hsieh C-S, Wang K-Y, Lin S-Y, Lee H-L, Lee C-H, Kuo H-C, Chen W-F, Jean Y-H. Intra-articular injection of the selective cyclooxygenase-2 inhibitor meloxicam (Mobic) reduces experimental osteoarthritis and nociception in rats.. Osteoarthritis and cartilage. 2013. DOI: 10.1016/j.joca.2013.09.005.

Предметные рубрики MeSH

Animals Anterior Cruciate Ligament Injuries Arthritis, Experimental Cartilage, Articular Chondrocytes Cyclooxygenase 2 Inhibitors Extracellular Signal-Regulated MAP Kinases Injections, Intra-Articular JNK Mitogen-Activated Protein Kinases Meloxicam Mitogen-Activated Protein Kinases Nociception Osteoarthritis, Knee Rats Rats, Wistar Synovial Membrane Thiazines Thiazoles p38 Mitogen-Activated Protein Kinases

Подготовка и перевод публикации

Обработка статьи · этапы, ошибки и управление

Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.